# Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma

> **NCT02420613** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 18 (estimated)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma

## Interventions

- **RADIATION:** Radiation Therapy
- **DRUG:** Temsirolimus
- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT02420613
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-05
- **Primary completion:** 2025-03-28
- **Final completion:** 2025-03-28
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02420613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02420613, "Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02420613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*